Cargando…

Clinical efficacy and safety of combination therapy of tocilizumab and steroid pulse therapy for critical COVID-19 in HD patients

BACKGROUND: Critical coronavirus disease 2019 (COVID-19) has a high fatality rate, especially in hemodialysis (HD) patients, with this poor prognosis being caused by systemic hyperinflammation; cytokine storms. Steroid pulse therapy or tocilizumab (TCZ) have insufficient inhibitory effects against c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Toda, Masataro, Fujii, Kentaro, Yoshifuji, Ayumi, Kondo, Yasushi, Itoh, Kazuto, Sekine, Kazuhiko, Kikuchi, Takahide, Ryuzaki, Munekazu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Singapore 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8390024/ https://www.ncbi.nlm.nih.gov/pubmed/34436742 http://dx.doi.org/10.1007/s10157-021-02126-4

Ejemplares similares

Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Correction to: Factors associated with SARS-CoV-2 antibody titers and prognosis of breakthrough infection in hemodialysis patients
por: Toda, Masataro, et al.
Publicado: (2022)

Patients with hemodialysis-induced hypoxemia had a poor prognosis of COVID-19
por: Toda, Masataro, et al.
Publicado: (2022)

Minimal Change Disease Associated With Durvalumab
por: Toda, Masataro G., et al.
Publicado: (2021)

A case of Bacillus subtilis var. natto bacteremia caused by ingestion of natto during COVID-19 treatment in a maintenance hemodialysis patient with multiple myeloma
por: Kato, Ai, et al.
Publicado: (2022)

Cellular and Humoral Immune Responses after Breakthrough Infection in Patients Undergoing Hemodialysis
por: Toda, Masataro, et al.
Publicado: (2023)

Chryseobacterium indologenes Peritonitis in a Peritoneal Dialysis Patient: A Case Report and Review of Literature
por: Miyakawa, Akira, et al.
Publicado: (2023)

COVID-19 vaccine induced interstitial lung disease
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Investigation for the efficacy of COVID-19 vaccine in Japanese CKD patients treated with hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

Committee report: Questionnaire survey on the treatment of COVID-19 in patients receiving dialysis therapy
por: Yoshifuji, Ayumi, et al.
Publicado: (2022)

T-Cell Response and Antibody Production Induced by the COVID-19 Booster Vaccine in Japanese Chronic Kidney Disease Patients Treated with Hemodialysis
por: Yoshifuji, Ayumi, et al.
Publicado: (2023)

Glomerulonephritis Caused by Bartonella spp. Infective Endocarditis: The Difficulty and Importance of Differentiation from Anti-neutrophil Cytoplasmic Antibody-related Rapidly Progressive Glomerulonephritis
por: Yoshifuji, Ayumi, et al.
Publicado: (2021)

Tocilizumab in sarcoidosis patients failing steroid sparing therapies and anti-TNF agents
por: Sharp, Michelle, et al.
Publicado: (2019)

Estimating immunity with mathematical models for SARS-CoV-2 after COVID-19 vaccination
por: Uwamino, Yoshifumi, et al.
Publicado: (2023)

Comparison of two protocols for steroid pulse therapy in patients with IgA nephropathy: a retrospective observational study
por: Yamatani, Satoshi, et al.
Publicado: (2022)

Tocilizumab, a Proposed Therapy for the Cachexia of Interleukin6-Expressing Lung Cancer
por: Ando, Katsutoshi, et al.
Publicado: (2014)

Tocilizumab and steroid treatment in patients with COVID-19 pneumonia
por: Mikulska, Malgorzata, et al.
Publicado: (2020)

The Treatment of COVID-19 Purgatory Syndrome With Tocilizumab and Steroids
por: Selvaraj, Vijairam, et al.
Publicado: (2022)

Cytomegalovirus Viremia, Pneumonitis, and Tocilizumab Therapy
por: van Duin, David, et al.
Publicado: (2011)

Tocilizumab as a steroid sparing agent for the treatment of Graves' orbitopathy
por: Russell, David J., et al.
Publicado: (2017)

Severe COVID-19 Pneumonia Treated by Intensive Immune Suppression Therapy With a Combination of Steroid Pulse and Tocilizumab Followed by a Tapering Dose of Steroid Therapy During the Delta (B.1.617.2) Variant Outbreak: A Successfully Treated Case
por: Muramatsu, Ken-ichi, et al.
Publicado: (2021)

Antiinflammatory effects of adalimumab, tocilizumab, and steroid on lipopolysaccharide-induced lung injury
por: SARIOĞLU, Nurhan, et al.
Publicado: (2021)

A case of Tocilizumab-induced thrombocytopenia in steroid-resistant Graves orbitopathy
por: Cuculescu, Victoria, et al.
Publicado: (2023)

Tocilizumab therapy for COVID-19: A comparison of subcutaneous and intravenous therapies
por: Kaminski, Monica A., et al.
Publicado: (2020)

Efficacy of Steroid Pulse Therapy for Autoimmune Pancreatitis Type 1: A Retrospective Study
por: Sugimoto, Mitsuru, et al.
Publicado: (2015)

Pulsed Vincristine Therapy in Steroid-Resistant Nephrotic Syndrome
por: Thalgahagoda, Shenal, et al.
Publicado: (2017)

PReS-FINAL-2110: Tocilizumab for patients with oligoarticular juvenile idiopathic arthritis refractory to conventional therapy
por: Sato, T, et al.
Publicado: (2013)

The Use of Single Therapy With Tocilizumab Versus Combination Therapy With Remdesivir and Tocilizumab in SARS-CoV-2 Patients in El Paso, Texas
por: Almaghlouth, Nouf K, et al.
Publicado: (2021)

An anterior mediastinal lesion in TAFRO syndrome showing complete remission after glucocorticoid and tocilizumab therapy
por: Sakashita, Kentaro, et al.
Publicado: (2016)

Tocilizumab for Covid-19 — The Ongoing Search for Effective Therapies
por: Huang, Edmund, et al.
Publicado: (2020)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Yang, Chengliang, et al.
Publicado: (2021)

Tocilizumab in COVID-19 therapy: who benefits, and how?
por: Neumann, Avidan U, et al.
Publicado: (2021)

Vogt–Koyanagi–Harada disease-like uveitis following nivolumab administration treated with steroid pulse therapy: a case report
por: Kikuchi, Ryo, et al.
Publicado: (2020)

A Neonate With Cytokine Storm Managed With Steroids, Therapeutic Plasma Exchange, and Tocilizumab
por: LiKamWa, Amy, et al.
Publicado: (2023)

Successful Treatment of Protein-Losing Gastroenteropathy with Steroid Pulse and Immunosuppressive Therapies in a Patient with Sjögren Syndrome
por: Nasu, Tetsushi, et al.
Publicado: (2011)

Efficacy of steroid pulse therapy for miliary tuberculosis complicated by acute respiratory distress syndrome
por: Wakamatsu, Kentaro, et al.
Publicado: (2022)

Pulse steroid therapy in acute airway obstruction in relapsing polychondritis
por: Butt, Sheraz, et al.
Publicado: (2009)

Favorable outcome in atheroembolic renal disease with pulse steroid therapy
por: Sharma, A., et al.
Publicado: (2012)

The efficacy of steroids for postoperative persistent inflammatory reaction in a patient with barium peritonitis: A case report
por: Kojima, Hirofumi, et al.
Publicado: (2017)

Steroid Therapy and Steroid Response in Autoimmune Pancreatitis
por: Matsubayashi, Hiroyuki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oepqme9sces7e1ogj2sgh143nq